Which statement indicates a need for further instruction regarding azathioprine (Imuran) for a post-kidney transplant client?

The statement indicating a need for further instruction regarding azathioprine (Imuran) for a post-kidney transplant client is that the medication should be discontinued after 14 days of use. This is inaccurate because azathioprine is typically prescribed as a long-term immunosuppressive treatment following an organ transplant. The goal of this medication is to prevent organ rejection by suppressing the immune system. Stopping it after a short period, such as 14 days, can increase the risk of transplant rejection or other complications related to the immune response.

The other statements reflect correct understanding or recommended practices. Taking azathioprine with meals can help reduce gastrointestinal side effects like nausea, which is beneficial for patient comfort and adherence to medication. Monitoring for signs of infection is crucial, as the immunosuppressive effects of azathioprine can make the patient more susceptible to infections. Moreover, knowing to contact the healthcare provider if multiple doses are missed emphasizes the importance of medication adherence and the potential consequences of inconsistent dosing on transplant success.